Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Five Events That Disrupted the Diabetes Market
Medical Devices and Diagnostics Industry
Fri, 03/9/18 - 10:47 am
Tags:
diabetes, devices, DexCom, blood glucose monitoring, Google, Verily, JNJ, Medtronic, MiniMed 670G, artificial pancreas, Abbott Labs, FDA, FreeStyle Libre Flash
U.S. judge says opioid settlement roadblocks may prompt trials
Reuters
Thu, 03/8/18 - 09:45 am
Tags:
opioids, opioid crisis, JNJ, Purdue Pharma, Allergan, Endo International, Teva Pharmaceutical
Senator questions big pharma buyback strategy
Biopharma Dive
Tue, 03/6/18 - 09:30 am
Tags:
Big Pharma, Pfizer, Merck, JNJ, AbbVie, Abbott Labs, share repurchase
Johnson & Johnson Advances in Robotics Surgery with Orthotaxy
Market Realist
Sat, 03/3/18 - 10:39 am
Tags:
JNJ, robotic surgery, devices, Orthotaxy, M&A
J&J collaborates with Aldeyra on new drugs for systemic inflammatory diseases
Endpoints
Tue, 02/27/18 - 09:49 am
Tags:
JNJ, Aldeyra Therapeutics, inflammatory disease, R&D
3 Big Drugmakers Boosting Huge R&D Budgets
Motley Fool
Sat, 02/24/18 - 11:23 am
Tags:
R&D, Bristol-Myers Squibb, Celgene, JNJ
Can Johnson & Johnson Replace Remicade for $100 Million Upfront?
Motley Fool
Wed, 02/21/18 - 09:40 am
Tags:
JNJ, Remicade, TD-1473, Theravance, JAK inhibitors, inflammatory bowel disease
J&J Acquisition Could Give Stryker a Run for Its Money in Robotics
Medical Devices and Diagnostics Industry
Tue, 02/20/18 - 10:35 pm
Tags:
JNJ, Stryker, robotics, Biogen M&A, Orthotaxy
J&J Is Exploring a Sale of Its $2 Billion Sterilization Division
Bloomberg
Tue, 02/20/18 - 09:15 am
Tags:
JNJ, M&A, sterilization, devices, ASP
Remicade biosims from Pfizer, Merck unlikely to turn the tide in 2018: analyst
Fierce Pharma
Fri, 02/16/18 - 09:29 pm
Tags:
Remicade, biosimilars, Pfizer, Merck, JNJ
A Possible Financial Boost Awaits Thousands Of Out-Of-State Plaintiffs In Risperdal suit
Forbes
Fri, 02/16/18 - 09:29 am
Tags:
Risperdal, Philadelphia, Janssen, JNJ
Johnson & Johnson’s stay-out-of-jail marketing for schizophrenia blockbuster Invega Sustenna raises eyebrows
Fierce Pharma
Thu, 02/15/18 - 11:46 pm
Tags:
JNJ, drug marketing, schizophrenia, Invega Sustenna
J&J gets first-of-its-kind prostate cancer approval
Biopharma Dive
Wed, 02/14/18 - 11:48 pm
Tags:
JNJ, apalutamide, prostate cancer
J&J strikes potential $1B JAK inhibitor deal with Theravance
Biopharma Dive
Wed, 02/7/18 - 10:06 am
Tags:
JNJ, JAK inhibitors, Theravance, TD-1473, drug development, Crohn's Disease, ulcerative colitis
Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J
JD Supra
Tue, 02/6/18 - 08:40 pm
Tags:
biosimilars, Pfizer, JNJ, antitrust, Remicade, Inflectra
How Johnson & Johnson Medical Devices Companies are working with healthcare customers to achieve the goal of value-based care
Medical Devices and Diagnostics Industry
Tue, 02/6/18 - 08:39 pm
Tags:
JNJ, devices, value-based care
Johnson & Johnson falls on report that lawsuits could expose potentially damaging documents
CNBC
Tue, 02/6/18 - 11:47 am
Tags:
JNJ, ovarian cancer
Strong data lift profile of J&J's cancer drug apalutamide
Biopharma Dive
Tue, 02/6/18 - 11:45 am
Tags:
JNJ, apalutamide, prostate cancer
Biopharma in charts: Key takeaways from Q4 earnings
Biopharma Dive
Mon, 02/5/18 - 12:35 pm
Tags:
earnings, Merck, JNJ, AbbVie, Roche, Celgene, Eli Lilly
[video]Johnson & Johnson's Earnings Were Solid, but Questions Remain
Motley Fool
Thu, 02/1/18 - 09:30 pm
Tags:
JNJ, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.